Easton Average Receivables from 2010 to 2026
Easton Pharmaceutica's Average Receivables is increasing with slightly volatile movements from year to year. Average Receivables is estimated to finish at about 201.4 K this year. For the period between 2010 and 2026, Easton Pharmaceutica, Average Receivables quarterly trend regression had mean deviation of 23,005 and range of 201.9 K. View All Fundamentals
Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
Average Receivables | First Reported 2010-12-31 | Previous Quarter 191.8 K | Current Value 201.4 K | Quarterly Volatility 48.8 K |
Check Easton Pharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Easton Pharmaceutica's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 161.2 K or Research Development of 179.8 K, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or PTB Ratio of 0.13. Easton financial statements analysis is a perfect complement when working with Easton Pharmaceutica Valuation or Volatility modules.
Easton | Average Receivables | Build AI portfolio with Easton Stock |
The Average Receivables trend for Easton Pharmaceutica offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Easton Pharmaceutica is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Easton Pharmaceutica's Average Receivables Growth Pattern
Below is the plot of the Average Receivables of Easton Pharmaceutica over the last few years. It is Easton Pharmaceutica's Average Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Easton Pharmaceutica's overall financial position and show how it may be relating to other accounts over time.
| Average Receivables | 10 Years Trend |
|
Average Receivables |
| Timeline |
Easton Average Receivables Regression Statistics
| Arithmetic Mean | 199,331 | |
| Geometric Mean | 177,618 | |
| Coefficient Of Variation | 24.48 | |
| Mean Deviation | 23,005 | |
| Median | 213,148 | |
| Standard Deviation | 48,794 | |
| Sample Variance | 2.4B | |
| Range | 201.9K | |
| R-Value | 0.35 | |
| Mean Square Error | 2.2B | |
| R-Squared | 0.12 | |
| Significance | 0.17 | |
| Slope | 3,362 | |
| Total Sum of Squares | 38.1B |
Easton Average Receivables History
About Easton Pharmaceutica Financial Statements
Investors use fundamental indicators, such as Easton Pharmaceutica's Average Receivables, to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Average Receivables | 191.8 K | 201.4 K |
Currently Active Assets on Macroaxis
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.